Abstract: A semiconductor device includes a vertical pattern including a first source/drain region, a second source/drain region on a level higher than that of the first source/drain region, and a vertical channel region between the first and second source/drain regions; and a gate structure disposed on a first side surface of the vertical pattern, wherein the gate structure includes a gate electrode including a gate electrode liner on the first surface of the vertical pattern and a gate electrode material layer on the gate electrode liner; a gate dielectric layer including a portion disposed between the vertical pattern and the gate electrode liner of the gate electrode; and at least one insulating barrier layer extending along at least one side of the gate electrode liner on the gate dielectric layer, wherein the at least one insulating barrier layer has a liner shape, with the gate electrode liner.

Abstract: Disclosed is a loop filter, comprising, a first single-amplifier biquad (SAB) integrator configured to apply an integration operation to an in-phase (I) input signal; a second SAB integrator configured to apply an integration operation to a quadrature (Q) input signal; a first cross-coupled path between an output terminal of the first SAB integrator and an input side of the second SAB integrator and configured to apply a first gain to an output voltage of the first SAB integrator; and a second cross-coupled path between an output terminal of the second SAB integrator and an input side of the first SAB integrator and configured to apply a negative of the first gain to an output voltage of the second SAB integrator.

Abstract: An analog-to-digital converter ADC includes a first successive approximation register analog-to-digital converter (SAR ADC) configured to convert an in-phase input signal to digital data using a first integrator, a second successive approximation register analog-to-digital converter (SAR ADC) configured to convert a quadrature input signal to digital data using a second integrator, and first to fourth sampling capacitors configured to transmit an output of the first integrator to an input terminal of the second integrator, and transmit an output of the second integrator to an input terminal of the first integrator when the first integrator and the second integrator integrate the sampled in-phase input signal and the quadrature input signal, respectively. The first and second SAR ADCs and the first to fourth sampling capacitors are driven according to an operation sequence of a sampling stage, a conversion stage, and an integration stage.

Abstract: The present invention generally relates to an extracellular vesicle (EV) comprising a subunit of a heterodimeric transcription factor, an EV polypeptide, and a monomeric cis-cleaving intein and a method of using the EV.

Abstract: The robot cleaner includes a case, a suction device provided in the case, a suction nozzle for sucking dust from a floor by driving of the suction device, a dust collection device for collecting foreign substances contained in the air sucked via the suction nozzle, a wheel unit to allow movement, a main controller for controlling the driving of the suction device and the wheel unit, a Wi-Fi module provided in the case to provide Access Point (AP), and a NFC module provided in the case to provide an external terminal with AP information for accessing to the AP through NFC communication.

Abstract: The robot cleaner includes a case, a suction device provided in the case, a suction nozzle for sucking dust from a floor by driving of the suction device, a dust collection device for collecting foreign substances contained in the air sucked via the suction nozzle, a wheel unit to allow movement, a main controller for controlling the driving of the suction device and the wheel unit, a Wi-Fi module provided in the case to provide Access Point (AP), and a NFC module provided in the case to provide an external terminal with AP information for accessing to the AP through NFC communication.

Abstract: The robot cleaner includes a case, a suction device provided in the case, a suction nozzle for sucking dust from a floor by driving of the suction device, a dust collection device for collecting foreign substances contained in the air sucked via the suction nozzle, a wheel unit to allow movement, a main controller for controlling the driving of the suction device and the wheel unit, a Wi-Fi module provided in the case to provide Access Point (AP), and a NFC module provided in the case to provide an external terminal with AP information for accessing to the AP through NFC communication.

Abstract: The robot cleaner includes a case, a suction device provided in the case, a suction nozzle for sucking dust from a floor by driving of the suction device, a dust collection device for collecting foreign substances contained in the air sucked via the suction nozzle, a wheel unit to allow movement, a main controller for controlling the driving of the suction device and the wheel unit, a Wi-Fi module provided in the case to provide Access Point (AP), and a NFC module provided in the case to provide an external terminal with AP information for accessing to the AP through NFC communication.

Abstract: The present invention provides monoclonal antibodies for human TrkB. In certain embodiments the inventive antibodies bind and activate human TrkB. In certain embodiments the inventive antibodies are selective for human TrkB in that they do not bind (or activate) human TrkA or human TrkC. In some embodiments the inventive monoclonal antibodies cross-react with murine TrkB. Humanized or veneered versions of the inventive antibodies are also encompassed. Pharmaceutical compositions that comprise inventive antibodies are provided as are methods for preparing the inventive antibodies and methods of using these for treatment, detection or purification purposes.

Abstract: The present invention provides monoclonal antibodies for human TrkB. In certain embodiments the inventive antibodies bind and activate human TrkB. In certain embodiments the inventive antibodies are selective for human TrkB in that they do not bind (or activate) human TrkA or human TrkC. In some embodiments the inventive monoclonal antibodies cross-react with murine TrkB. Humanized or veneered versions of the inventive antibodies are also encompassed. Pharmaceutical compositions that comprise inventive antibodies are provided as are methods for preparing the inventive antibodies and methods of using these for treatment, detection or purification purposes.

Abstract: The present invention provides monoclonal antibodies for human TrkB. In certain embodiments the inventive antibodies bind and activate human TrkB. In certain embodiments the inventive antibodies are selective for human TrkB in that they do not bind (or activate) human TrkA or human TrkC. In some embodiments the inventive monoclonal antibodies cross-react with murine TrkB. Humanized or veneered versions of the inventive antibodies are also encompassed. Pharmaceutical compositions that comprise inventive antibodies are provided as are methods for preparing the inventive antibodies and methods of using these for treatment, detection or purification purposes.